KRAS and cancer: Mutation and activation of the three RAS genes (KRAS, HRAS, and NRAS) are recognized in about 25% of human cancers, with Kirsten Rat Sarcoma viral oncogene homolog (KRAS) playing a significant role in the development of tumors [18].